Buy DLF, target of Rs 330: Emkay Global

Published on Wed, Nov 05, 2008 at 12:12 |  Source : Moneycontrol.com

Updated at Wed, Nov 05, 2008 at 12:19  

121708 Investors following DLF. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Emkay Global Financial Services has maintained its buy rating on DLF with a target of Rs 330 in its November 4, 2008 research report. "Revenue and net profit for the quarter stood at Rs 37.4 billion and Rs 19.3 billion respectively (against our estimates of Rs 40.2 billion and Rs 20.9 billion)."

"We expect the company to report revenue of Rs 206.4 billion in FY09 and Rs 312.9 billion in FY10. Net profit for FY09 and FY10 is estimated to be Rs 104.5 billion and Rs 146.0 billion respectively. The stock trades at 4.7 x FY09 and 3.4 x FY10. We are revising our NAV estimates from Rs 840 earlier to Rs 660, due to a) higher cost of funds b) excluding long gestation projects like Biddadi from our estimates. We maintain our BUY on the stock with target price of Rs 330 (earlier Rs 672) based on 50% discount to NAV," says Emkay Global Financial Services' research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com